We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener

Session

Poster: Prostate
Poster
World Congress of Brachytherapy 2021
Subdomains of erectile and urinary function after ultrafocal HDR-brachytherapy for prostate cancer
PO-0230
Using PSA Kinetics to Predict 5-yr Biochemical Failure in Intermediate-Risk Prostate Cancer Patients
PO-0231
Permanent seed prostate brachytherapy : long term results of a large single center
PO-0232
A multi-protocol validation study of automated bi-objective planning for HDR prostate brachytherapy
PO-0233
Feasibility in using a nomogram as an independent verification process in HDR prostate brachytherapy
PO-0234
HDR Prostate Brachytherapy – Is 20 needles too many?
PO-0235
HDR monotherapy for low and intermediate risk prostate cancer in one or two fractions
PO-0236
HDR monotherapy (2 fractions/13,5 Gy) in LR and favorable IR prostate cancer: analysis of toxicity.
PO-0237
LDR-HDR boost in patients with intermediate-risk prostate cancer. A single Institution experience.
PO-0238
20 Gy HDR brachytherapy as monotherapy for localized prostate cancer: Early outcomes
PO-0239
EAU eligibility criteria for exclusive 125I brachytherapy for intermediate risk prostate cancer
PO-0241
Treatment outcomes and toxicity in patients treated with LDR brachytherapy, single institution study
PO-0242
HDR brachytherapy as monotherapy or a boost for high risk prostate cancer: 5 year single center data
PO-0243
HDR brachytherapy monotherapy with 2 x 13.5 Gy for localized prostate cancer: short term follow up
PO-0244
HDR Monotherapy/LDR-EBRT/HDR-EBRT in patients with favorable IR prostate cancer: Long term results.
PO-0245
Cost-effectiveness analysis of the use of blood patch as a pre-rectal spacer in brachytherapy.
PO-0246
Prostate HDR boost: urethra V110 constraints correspond to low adverse effects
PO-0247
The one-hundred most-cited publications in prostate brachytherapy
PO-0248
Comparison of two different Low Dose Rate (LDR) Brachytherapy techniques - a retrospective analysis
PO-0249
MRI-Guided Robotic Prostate Biopsy and Brachytherapy: Update from the EU-funded CoBra Project
PO-0250
clinical outcomes of radiation therapy for high-risk prostate cancer
PO-0251
Technical Evaluation of 3D printed Disposable Seed Loader for LDR Cs-131 Prostate Brachytherapy
PO-0252
Real-time intraoperative-planning reduces toxicity in LDR-brachytherapy-boost in prostate cancer
PO-0253